Learn More
Description
TRANCE/RANKL/OPGL/ODF is a recently identified member of the tumor necrosis factor family. TRANCE (TNF-Related Activation-Induced Cytokine Receptor) or RANKL (Receptor Activator of NF-kB Ligand) has been implicated in interactions between T cells and dendritic cells. TRANCE/RANKL binds to RANK on dendritic cells, upregulates the expression of anti-apoptotic protein BcL-XL suggesting a role in dendritic cell survival. TRANCE/RANKL is also important in T- and B-cell maturation. As OPGL/ODF (Osteoprotegerin Ligand/Osteoclast Differentiation Factor), the same protein can both activate mature osteoclasts and mediate osteoclastogenesis. OPGL/TRANCE deficient mice show severe osteoporesis and complete absence of osteoclasts as a result of lack of osteogenesis. It is expressed abundantly by mouse activated T cells, not B cells. It is also expressed on osteoclasts.
Host Species: Rat
Clone: IK22-5
Isotype: IgG2a κ
Species Reactivity: Mouse
Immunogen: Mouse recombinant RANKL
Flow Cytometry
Specifications
Specifications
| Antigen | RANKL/TRANCE |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | IK22-5 |
| Concentration | 0.2mg/mL |
| Conjugate | PE |
| Description | TRANCE, TRANCEODF, OPGL, sOdf, CD254, OPTB2, hRANKL2 |
| Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
| Host Species | Rat |
| Immunogen | Mouse recombinant RANKL |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.